Synthomer plc (LON:SYNT - Get Free Report) shares rose 11% during mid-day trading on Friday . The company traded as high as GBX 92.15 ($1.22) and last traded at GBX 88.16 ($1.17). Approximately 11,893,332 shares were traded during trading, an increase of 1,243% from the average daily volume of 885,594 shares. The stock had previously closed at GBX 79.40 ($1.05).
Wall Street Analyst Weigh In
Separately, Berenberg Bank downgraded Synthomer to a "hold" rating and reduced their target price for the company from GBX 230 ($3.04) to GBX 150 ($1.99) in a research report on Wednesday, March 12th.
Read Our Latest Analysis on Synthomer
Synthomer Trading Down 2.4 %
The firm has a market capitalization of £135.94 million, a P/E ratio of -1.66, a PEG ratio of -0.17 and a beta of 1.79. The business has a 50 day moving average of GBX 119.79 and a 200-day moving average of GBX 150.03. The company has a current ratio of 1.90, a quick ratio of 0.97 and a debt-to-equity ratio of 78.27.
Synthomer (LON:SYNT - Get Free Report) last posted its quarterly earnings results on Wednesday, March 12th. The company reported GBX (3.50) (($0.05)) earnings per share for the quarter. Synthomer had a negative net margin of 4.40% and a negative return on equity of 7.52%. Analysts anticipate that Synthomer plc will post 12.962963 EPS for the current fiscal year.
Synthomer Company Profile
(
Get Free Report)
Synthomer plc operates as a specialty chemicals company in the United Kingdom and internationally. It operates through five segments: Performance Elastomers, Functional Solutions, Industrial Specialities, Acrylate Monomers, and Adhesive Technologies. The company offers adhesives, including PSA labels, packaging and specialty tapes, saturants, release coatings, wood working, wet glues, hygiene and contact adhesives, packaging and assembly hot melt adhesives; coatings products such as architectural, masonry, intumescent, metal, wood, soil releases, blinders, ink receptive, polyester for powder coatings, SYNTHOMER NX for coalescing agents, and SYNOLOX BEPF for glycol.
Read More
Before you consider Synthomer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.
While Synthomer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
